| RYVU THERAPEUTICS ZY-,40 |
| Polen |
| Gesundheit |
| PLSELVT00013 / A1JUH2 |
| 9Y4 (Frankfurt) |
| FRA:9Y4, ETR:9Y4, 9Y4:GR |
| - |
| https://ryvu.com/ |
|
Ryvu Therapeutics S.A. is a biotechnology company specializing in the research and development of novel small-molecule therapies targeting high-value emerging biological targets. The primary purpose of Ryvu Therapeutics is to develop innovative treat..
>Volltext.. |
| 124.09 Mio. EUR |
| 115.7 Mio. EUR |
| 15 Mio. EUR |
| -27.16 Mio. EUR |
| -24.4 Mio. EUR |
| -1.06 EUR |
| 17.29 Mio. EUR |
| 14.37 Mio. EUR |
| -26.58 Mio. EUR |
| 1.75 |
| -20.15% |
| 9.16% |
| - |
| - |
| - |
| - |
| RYVU |
| 05.04.26 |
|